Business Description
Gulf Pharmaceutical Industries PSC
ISIN : AEG000201018
Compare
Compare
Traded in other countries / regions
JULPHAR.United Arab Emirates IPO Date
2002-10-20Description
Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 1.25 | |||||
| Debt-to-EBITDA | 9.07 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 1.2 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 50.4 | |||||
| 3-Year EPS without NRI Growth Rate | 67.7 | |||||
| 3-Year FCF Growth Rate | 37.4 | |||||
| 3-Year Book Growth Rate | -5.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.28 | |||||
| 9-Day RSI | 46.65 | |||||
| 14-Day RSI | 46.13 | |||||
| 6-1 Month Momentum % | -9.14 | |||||
| 12-1 Month Momentum % | -32.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.13 | |||||
| Quick Ratio | 1.22 | |||||
| Cash Ratio | 0.25 | |||||
| Days Inventory | 209.14 | |||||
| Days Sales Outstanding | 131.93 | |||||
| Days Payable | 143.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.3 | |||||
| Shareholder Yield % | -11.5 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.53 | |||||
| Operating Margin % | -7.89 | |||||
| Net Margin % | -4.88 | |||||
| ROE % | -8.69 | |||||
| ROA % | -3.23 | |||||
| ROIC % | -7.3 | |||||
| ROC (Joel Greenblatt) % | -1.2 | |||||
| ROCE % | -1.07 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 8.38 | |||||
| PS Ratio | 0.58 | |||||
| PB Ratio | 1.11 | |||||
| Price-to-Tangible-Book | 1.34 | |||||
| EV-to-EBIT | -96.24 | |||||
| EV-to-EBITDA | 15.48 | |||||
| EV-to-Revenue | 1.12 | |||||
| EV-to-FCF | -33.84 | |||||
| Price-to-Projected-FCF | 4.15 | |||||
| Price-to-Median-PS-Value | 0.26 | |||||
| Earnings Yield (Greenblatt) % | -1.04 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gulf Pharmaceutical Industries PSC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil د.إ) | 1,636.9 | ||
| EPS (TTM) (د.إ) | -0.069 | ||
| Beta | 0 | ||
| Volatility % | 19.6 | ||
| 14-Day RSI | 46.13 | ||
| 14-Day ATR (د.إ) | 0.013225 | ||
| 20-Day SMA (د.إ) | 0.83845 | ||
| 12-1 Month Momentum % | -32.95 | ||
| 52-Week Range (د.إ) | 0.805 - 1.3 | ||
| Shares Outstanding (Mil) | 1,155.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gulf Pharmaceutical Industries PSC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gulf Pharmaceutical Industries PSC Stock Events
| Event | Date | Price(د.إ) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gulf Pharmaceutical Industries PSC Frequently Asked Questions
What is Gulf Pharmaceutical Industries PSC(ADX:JULPHAR)'s stock price today?
The current price of ADX:JULPHAR is د.إ0.83. The 52 week high of ADX:JULPHAR is د.إ1.30 and 52 week low is د.إ0.81.
When is next earnings date of Gulf Pharmaceutical Industries PSC(ADX:JULPHAR)?
The next earnings date of Gulf Pharmaceutical Industries PSC(ADX:JULPHAR) is .
Does Gulf Pharmaceutical Industries PSC(ADX:JULPHAR) pay dividends? If so, how much?
Gulf Pharmaceutical Industries PSC(ADX:JULPHAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers